Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure

Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT; Hemodynamically Guided...

(2010), Circulation, 121(9), 1086-95

Is target dose of beta-blocker more important than achieved heart rate or heart rate change in patients with systolic chronic heart failure?

Porapakkham P, Porapakkham P, Krum H

(2010), Cardiovasc Ther, 28(2), 93-100

Effect of valsartan on the incidence of diabetes and cardiovascular events

NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR...

(2010), N Engl J Med, 362(16), 1477-90

B-type natriuretic peptide-guided heart failure therapy: a meta-analysis

Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H

(2010), Arch Intern Med, 170(6):, 507-14

The future of pharmacological therapy for heart failure

Sata Y, Krum H

(2010), Circ J, 74(5), 809-17

Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension

Schlaich MP, Krum H, Sobotka PA

(2010), Curr Hypertens Rep, 12(1), 39-46

Effect of the urotensin receptor antagonist palosuran in hypertensive patients with Type 2 diabetic nephropathy

Vogt L, Chiurchiu C, Chadha-Boreham H, Danaietash P, Dingemanse J, Hadjadj S, Krum H, Navis G, Neuhart E, Parvanova AI, Ruggenenti P, Woittiez AJ, Zimlichman R, Remuzzi G, de Zeeuw D; PROLONG (PROteinuria Lowering with urOteNsin...

(2010), Hypertension, 55(5), 1206-9

Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients

Wein S, Voskoboinik A, Wein L, Billah B, Krum H

(2010), J Card Fail, 16(5), 432-8

New therapeutic approaches to resistant hypertension

Schlaich MP, Krum H, Esler MD

(2010), Curr Hypertens Rep, 12(4), 296-302

Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone

Wang BH, Bertucci MC, Ma JY, Adrahtas A, Cheung RY, Krum H

(2010), Clin Exp Pharmacol Physiol, 37(9), 912-8

Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy

Kompa AR, Wang BH, Phrommintikul A, Ho PY, Kelly DJ, Behm DJ, Douglas SA, Krum H

(2010), Peptides, 31(8), 1523-30

Pilot study of the prevalence, outcomes and detection of occult hypoperfusion in trauma patients

Thom O, Taylor DM, Wolfe RE, Myles P, Krum H, Wolfe R

(2010), Emerg Med J, 27(6), 470-2

Renin inhibitors in chronic heart failure: the Aliskiren Observation of Heart Failure Treatment study in context

Krum H, Maggioni A

(2010), Clin Cardiol, 33(9), 536-41

Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial

Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV, Arterburn S, Sager P, Weber M

(2010), Hypertension, 56(5), 824-30

Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting

Lam LL, Cameron PA, Schneider HG, Abramson MJ, Müller C, Krum H

(2010), Ann Intern Med, 153(11), 728-35

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M

(2010), Lancet, 376(9756), 1903-9

Volatile anaesthetic myocardial protection: a review of the current literature

Lin E, Symons JA

(2010), HSR Proceedings Intens Care Cardiovasc Anaes, 2(2), 7-11

Brain natriuretic peptide (BNP) as a biomarker of myocardial ischemia-reperfusion injury in cardiac transplantation

McIlroy DR, Wallace S, Roubos N

(2010), J Cardiothorac Vasc Anesth, 24(6), 939-45

No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial

Hindman BJ, Bayman EO, Pfisterer WK, Torner JC, Todd MM; IHAST Investigators

(2010), Anesthesiology, 112(1), 86-101

Intraoperative nitrous oxide as a preventive analgesic

Stiglitz DK, Amaratunge LN, Konstantatos AH, Lindholm DE

(2010), Anaesth Intensive Care, 38(5), 890-3

658 659 660 661 662